Biotech

All Articles

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened a $700 million R&ampD facility in the Boston Seaport, boosting its RNA and DNA...

Boundless Bio makes 'reasonable' layoffs 5 months after $100M IPO

.Simply five months after securing a $one hundred million IPO, Boundless Biography is actually givin...

Halda's $126M will accelerate 'keep as well as kill' lump medications

.The preliminary stages of oncology R&ampD may not be except intriguing brand-new techniques, and Ha...

Lykos 'disappointments' certainly not disclosing study violations with publisher

.Psychopharmacology has pulled 3 articles regarding midstage scientific test information determining...

Analysts explore Avidity's DMD win, exposing distinctions in data

.Avidity Biosciences pleased investors along with period 1/2 records in Duchenne muscular dystrophy ...

Actinogen's cortisol blocker neglects phase 2 depression study

.Actinogen Medical's cortisol blocker has missed the main endpoint of a stage 2 research in depressi...

Bivictrix determines going personal only technique to take ADC in to facility

.Antibody-drug conjugates (ADCs) have actually been at the facility of many a billion-dollar biobuck...

TPG leadings up funds to $580M for assets around lifestyle sciences

.Resource manager TPG, which has supported biotechs including Sionna Therapeutics and Santa Ana Biog...

Merck ceases phase 3 TIGIT trial in lung cancer cells for impossibility

.Merck &amp Co.'s TIGIT plan has suffered another trouble. Months after shuttering a phase 3 melanom...

After a difficult year, Exscientia folds up right into Recursion

.After a year specified by pipe hairstyles, the shift of its CEO and unemployments, Exscientia will ...